Toll Free: 1-888-928-9744

Trinity Biotech Plc (TRIB) - Product Pipeline Analysis, 2016 Update

Published: Jun 29, 2016 | Pages: 51 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company's product portfolio encompasses diagnostic tests and instruments that are used to detect haemoglobin A1c for diabetes monitoring and diagnosis, infectious diseases, autoimmune, sexually transmitted diseases, liver and intestine disorders. It also offers raw materials to research and life sciences sectors.  Trinity Biotech markets its products through direct sales in the US, Germany, France and the UK; and through a network of distributors and strategic partnerships in other countries. The company has manufacturing facilities in the US and Ireland. Trinity Biotech is headquartered in Co. Wicklow, Ireland.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Trinity Biotech Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Trinity Biotech Plc Company Snapshot 6 Trinity Biotech Plc Company Overview 6 Trinity Biotech Plc Pipeline Products and Clinical Trials Overview 7 Trinity Biotech Plc - Pipeline Analysis Overview 10 Business Description 10 Key Facts 11 Trinity Biotech Plc - Major Products and Services 12 Trinity Biotech Plc Pipeline Products by Development Stage 13 Trinity Biotech Plc Pipeline Products Overview 15 BNP Test - POC 15 BNP Test - POC Product Overview 15 D-dimer Test 16 D-dimer Test Product Overview 16 Diagnostic Assay - Dengue 17 Diagnostic Assay - Dengue Product Overview 17 Diagnostic Test - Adenovirus/Rotavirus 18 Diagnostic Test - Adenovirus/Rotavirus Product Overview 18 Meritas Point of Care Analyzer 19 Meritas Point of Care Analyzer Product Overview 19 Meritas Troponin I Test 20 Meritas Troponin I Test Product Overview 20 Multiplex Cardiac Panel 21 Multiplex Cardiac Panel Product Overview 21 Uni-Gold Chlamydia Test 22 Uni-Gold Chlamydia Test Product Overview 22 Uni-Gold Faecal Occult Blood Test 23 Uni-Gold Faecal Occult Blood Test Product Overview 23 Uni-Gold H. pylori Ag Test 24 Uni-Gold H. pylori Ag Test Product Overview 24 Uni-Gold HIV Ag/Ab Combo Test 25 Uni-Gold HIV Ag/Ab Combo Test Product Overview 25 Uni-Gold Infectious Mononucleosis Test 26 Uni-Gold Infectious Mononucleosis Test Product Overview 26 Uni-Gold Malaria Test 27 Uni-Gold Malaria Test Product Overview 27 Uni-Gold RSV Test 28 Uni-Gold RSV Test Product Overview 28 Uni-Gold S. Pneumoniae Test 29 Uni-Gold S. Pneumoniae Test Product Overview 29 Uni-Gold Strep B Test 30 Uni-Gold Strep B Test Product Overview 30 Uni-Gold Syphilis-Combo 31 Uni-Gold Syphilis-Combo Product Overview 31 Uni-Gold Tuberculosis Test 32 Uni-Gold Tuberculosis Test Product Overview 32 Trinity Biotech Plc - Key Competitors 33 Trinity Biotech Plc - Key Employees 34 Trinity Biotech Plc - Key Employee Biographies 35 Trinity Biotech Plc - Locations And Subsidiaries 36 Head Office 36 Other Locations & Subsidiaries 36 Recent Developments 38 Trinity Biotech Plc, Recent Developments 38 Apr 19, 2016: Trinity Biotech Announces Results for Q1, 2016 38 Mar 03, 2016: Trinity Biotech Announces Results for Q4 and Fiscal Year 2015 39 Dec 17, 2015: Trinity Biotech Announces FDA Submission of High Sensitivity Troponin I Product 41 Jul 28, 2015: Trinity Biotech Announces Quarter 2 Financial Results Enrolment for the Meritas Troponin ACS Study Now Completed 41 Apr 30, 2015: Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend of 22 Cents 43 Mar 03, 2015: Trinity Biotech Announces Results for Q4 and Fiscal Year 2014 45 Feb 23, 2015: Trinity Biotech Announces Recommencement of US Clinical Trials on its Point-of-Care, High Sensitivity Troponin I Product 47 Dec 16, 2014: Trinity Biotech Announces CLIA Waiver of Rapid Syphilis Test 48 Oct 23, 2014: Trinity Biotech announces Quarter 3 Financial Results 48 Oct 23, 2014: Trinity Biotech Provides Update On Sales Of Premier In Q3 2014 50 Appendix 51 Methodology 51 About GlobalData 51 Contact Us 51 Disclaimer 51
List of Tables
Trinity Biotech Plc Pipeline Products and Clinical Trials Overview 7 Trinity Biotech Plc Pipeline Products by Equipment Type 7 Trinity Biotech Plc Pipeline Products by Indication 9 Trinity Biotech Plc, Key Facts 11 Trinity Biotech Plc, Major Products and Services 12 Trinity Biotech Plc Number of Pipeline Products by Development Stage 13 Trinity Biotech Plc Pipeline Products Summary by Development Stage 14 BNP Test - POC - Product Status 15 BNP Test - POC - Product Description 15 D-dimer Test - Product Status 16 D-dimer Test - Product Description 16 Diagnostic Assay - Dengue - Product Status 17 Diagnostic Assay - Dengue - Product Description 17 Diagnostic Test - Adenovirus/Rotavirus - Product Status 18 Diagnostic Test - Adenovirus/Rotavirus - Product Description 18 Meritas Point of Care Analyzer - Product Status 19 Meritas Point of Care Analyzer - Product Description 19 Meritas Troponin I Test - Product Status 20 Meritas Troponin I Test - Product Description 20 Multiplex Cardiac Panel - Product Status 21 Multiplex Cardiac Panel - Product Description 21 Uni-Gold Chlamydia Test - Product Status 22 Uni-Gold Chlamydia Test - Product Description 22 Uni-Gold Faecal Occult Blood Test - Product Status 23 Uni-Gold Faecal Occult Blood Test - Product Description 23 Uni-Gold H. pylori Ag Test - Product Status 24 Uni-Gold H. pylori Ag Test - Product Description 24 Uni-Gold HIV Ag/Ab Combo Test - Product Status 25 Uni-Gold HIV Ag/Ab Combo Test - Product Description 25 Uni-Gold Infectious Mononucleosis Test - Product Status 26 Uni-Gold Infectious Mononucleosis Test - Product Description 26 Uni-Gold Malaria Test - Product Status 27 Uni-Gold Malaria Test - Product Description 27 Uni-Gold RSV Test - Product Status 28 Uni-Gold RSV Test - Product Description 28 Uni-Gold S. Pneumoniae Test - Product Status 29 Uni-Gold S. Pneumoniae Test - Product Description 29 Uni-Gold Strep B Test - Product Status 30 Uni-Gold Strep B Test - Product Description 30 Uni-Gold Syphilis-Combo - Product Status 31 Uni-Gold Syphilis-Combo - Product Description 31 Uni-Gold Tuberculosis Test - Product Status 32 Uni-Gold Tuberculosis Test - Product Description 32 Trinity Biotech Plc, Key Employees 34 Trinity Biotech Plc, Key Employee Biographies 35 Trinity Biotech Plc, Subsidiaries 36


List of Figures
Trinity Biotech Plc Pipeline Products by Equipment Type 8 Trinity Biotech Plc Pipeline Products by Development Stage 13

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the marke

Read More...

Global agricultural films market size is anticipated to reach USD 10.5 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to raise agricultural productivity, in order to meet surplus demand by growing population i

Read More...

Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving cream

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet o

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify